Ticker

JPMorgan Chase and Co. reduced its position in shares of Global Medical REIT Inc. (NYSE: XRN) by 72.8% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 109,144 shares of the company's stock after selling 291,977 shares during the quarter. JPMorgan Chase and

Shares of Global Medical REIT Inc. (NYSE: GMRE - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the six research firms that are presently covering the company, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold rating, two have given a buy rating and one has given

FrontView REIT (NYSE: FVR - Get Free Report) and Global Medical REIT (NYSE: GMRE - Get Free Report) are both small-cap finance companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, risk, institutional ownership, dividends, profitability, valuation and analyst recommendations. Valuation and Earnings This table compares

BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), announced today that it intends to release its fourth quarter and year-end 2025 financial results after the market closes on Wednesday, February 25, 2026. The Company intends to hold a conference call to discuss those results the following day, Thursday, February 26, 2026, at 9:00 a.m. Eastern Time. The conference call…

Shares of Global Medical REIT Inc. (NYSE: GMRE - Get Free Report) have been given a consensus rating of "Moderate Buy" by the seven research firms that are covering the firm, MarketBeat.com reports. Three research analysts have rated the stock with a hold recommendation, three have given a buy recommendation and one has given a strong